journal article·2025-04-01Open access

Potassium-Doped MnO2 Nanoparticles Reprogram Neutrophil Calcium Signaling to Accelerate Healing of Methicillin-Resistant Staphylococcus aureus-Infected Diabetic Wounds

Jianxu Wei, Xiaomeng Zhang, Baiyan Sui, Xinxin Ding, Yuan Li, Beilei Liu, Jiale Wang, Xiaolei Lv, Yi Zhang, Xue Jiang, Yijie Yang, Hongchang Lai, Xin Liu, Junyu Shi

ACS Nano· Volume 19· Issue 12

Abstract

High Resolution Image Download MS PowerPoint Slide Neutrophils, as first-line immune cells, typically lose their edge within the diabetic wounds accompanied by methicillin-resistant Staphylococcus aureus (MRSA) infections (the D/M setting), playing the role of “more foe than friend” during the healing process. Specifically, reduced influx of calcium ions (Ca 2+ ) and impaired calcium homeostasis yield the dysfunction of neutrophil sequential behaviors in pathogen killing and wound healing, manifesting as suppressed chemotaxis, decreased intracellular reactive oxygen species (ROS) generation, prolonged apoptosis, and retention of neutrophil extracellular traps (NETs). To address this challenge, this study fabricated potassium (K)-doped manganese dioxide nanoparticles (MnO 2 NPs), which activated transmembrane Ca 2+ channels by inducing neutrophil depolarization via electron transfer. Subsequently, this contributed to the initial Ca 2+ influx and reprogrammed Ca 2+ -dependent behaviors of impaired neutrophils. Also, the potential antimicrobial capacity of K-MnO 2 NPs created a favorable extracellular environment that restored calcium homeostasis, enabling apoptotic neutrophils to be removed timely. Therefore, the wounds treated with K-MnO 2 NPs in the D/M setting exhibited potent resistance to MRSA and rapid healing, which could be attributed to the synergistic effects of K-MnO 2 NPs in leveraging Ca 2+ influx and maintaining calcium homeostasis. In brief, K-MnO 2 NPs constitute an effective strategy to resist MRSA and rapid wound healing in the D/M setting.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Wound Healing and Treatments · S100 Proteins and Annexins

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oral and Maxillofacial Implantology

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology

Department of Dental Materials, Shanghai Biomaterials Research & Testing Center

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology

College of Physics

Donghua University

Shanghai Institute of Intelligent Electronics and Systems

Funding

National Natural Science Foundation of China · Shanghai Rising-Star Program · Biobank Project of Ninth People???s Hospital Affiliated Shanghai Jiao Tong University School of Medicine · Biomaterials and Regenerative Medicine Institute Cooperative Research Project by Shanghai Jiao Tong University School of Medicine · Shanghai Young Talents in Healthcare · Shanghai Pujiang Program · Cross-disciplinary Research Fund of Shanghai Ninth People???s Hospital, Shanghai Jiao Tong University School of Medicine

References (71)

Show source-provided references
1. 10.1016/j.cej.2023.14464910.1016/j.cej.2023.144649 ↗
2. 10.1126/sciadv.adh141510.1126/sciadv.adh1415 ↗
3. 10.1016/j.carbpol.2023.12082410.1016/j.carbpol.2023.120824 ↗
4. 10.1038/s41578-022-00426-z10.1038/s41578-022-00426-z ↗
5. 10.1093/rb/rbw04110.1093/rb/rbw041 ↗
6. 10.1172/JCI12461610.1172/JCI124616 ↗
7. 10.3389/fimmu.2022.86674710.3389/fimmu.2022.866747 ↗
8. 10.1111/j.1742-481X.2012.01057.x10.1111/j.1742-481X.2012.01057.x ↗
9. 10.1152/physrev.00052.200910.1152/physrev.00052.2009 ↗
10. 10.1089/dia.2004.6.88710.1089/dia.2004.6.887 ↗
11. 10.1208/s12248-010-9175-310.1208/s12248-010-9175-3 ↗
12. 10.4161/viru.2690710.4161/viru.26907 ↗
13. 10.1590/S1413-8670200200040000710.1590/S1413-86702002000400007 ↗
14. 10.1189/jlb.121160110.1189/jlb.1211601 ↗
15. 10.1073/pnas.141405511210.1073/pnas.1414055112 ↗
16. 10.1002/JLB.3RU0719-241R10.1002/JLB.3RU0719-241R ↗
17. 10.3390/toxins807020910.3390/toxins8070209 ↗
18. 10.1128/IAI.00787-1210.1128/IAI.00787-12 ↗
19. 10.1101/cshperspect.a00394710.1101/cshperspect.a003947 ↗
20. 10.1002/advs.20200439310.1002/advs.202004393 ↗
21. 10.3390/nano804021210.3390/nano8040212 ↗
22. 10.1021/acsami.9b0387910.1021/acsami.9b03879 ↗
23. 10.3389/fbioe.2021.78857410.3389/fbioe.2021.788574 ↗
24. 10.1007/s13369-013-0545-x10.1007/s13369-013-0545-x ↗
25. 10.1021/ic990456l10.1021/ic990456l ↗
26. 10.1016/j.jcis.2017.09.04310.1016/j.jcis.2017.09.043 ↗
27. 10.1038/s41467-022-30148-310.1038/s41467-022-30148-3 ↗
28. 10.1182/blood-2010-01-25902810.1182/blood-2010-01-259028 ↗
29. 10.1038/s41590-021-00968-410.1038/s41590-021-00968-4 ↗
30. 10.1002/adma.20221155510.1002/adma.202211555 ↗
31. 10.1016/j.micres.2020.12664410.1016/j.micres.2020.126644 ↗
32. 10.1021/acsami.2c1150310.1021/acsami.2c11503 ↗
33. 10.1039/D2BM01460B10.1039/D2BM01460B ↗
34. 10.1016/j.vph.2022.10699810.1016/j.vph.2022.106998 ↗
35. 10.2174/09298671079041629010.2174/092986710790416290 ↗
36. 10.1002/tcr.20220011810.1002/tcr.202200118 ↗
37. 10.1016/j.ceramint.2022.05.09410.1016/j.ceramint.2022.05.094 ↗
38. 10.1021/acsnano.0c0349610.1021/acsnano.0c03496 ↗
39. 10.1021/acsami.6b1685610.1021/acsami.6b16856 ↗
40. 10.1021/acs.langmuir.5b0226610.1021/acs.langmuir.5b02266 ↗
41. 10.1007/s11356-022-22835-x10.1007/s11356-022-22835-x ↗
42. 10.3390/app1213682110.3390/app12136821 ↗
43. 10.1038/s41467-018-04998-910.1038/s41467-018-04998-9 ↗
44. 10.1021/am505571m10.1021/am505571m ↗
45. 10.1016/j.bioactmat.2021.02.02510.1016/j.bioactmat.2021.02.025 ↗
46. 10.1089/wound.2012.038310.1089/wound.2012.0383 ↗
47. 10.1002/mbo3.126010.1002/mbo3.1260 ↗
48. 10.1007/s00441-017-2785-710.1007/s00441-017-2785-7 ↗
49. 10.1016/j.celrep.2023.11328110.1016/j.celrep.2023.113281 ↗
50. Daniella I. · 2019 · 2
51. 10.1002/JLB.3A0820-207R10.1002/JLB.3A0820-207R ↗
52. 10.3389/fonc.2022.94449410.3389/fonc.2022.944494 ↗
53. 10.3390/ijms1910321710.3390/ijms19103217 ↗
54. 10.3390/antibiotics802005410.3390/antibiotics8020054 ↗
55. 10.1016/j.molcel.2022.04.03210.1016/j.molcel.2022.04.032 ↗
56. 10.1146/annurev-immunol-032414-11221210.1146/annurev-immunol-032414-112212 ↗
57. 10.1073/pnas.200803211710.1073/pnas.2008032117 ↗
58. 10.1039/c3nr01667f10.1039/c3nr01667f ↗
59. 10.3389/fimmu.2021.63182110.3389/fimmu.2021.631821 ↗
60. 10.1111/j.1365-2958.2008.06425.x10.1111/j.1365-2958.2008.06425.x ↗
61. 10.1182/blood-2008-06-16240410.1182/blood-2008-06-162404 ↗
62. 10.1038/cdd.2011.16710.1038/cdd.2011.167 ↗
63. 10.1038/nature0829610.1038/nature08296 ↗
64. 10.1016/j.immuni.2019.04.01810.1016/j.immuni.2019.04.018 ↗
65. 10.3389/fimmu.2020.0055310.3389/fimmu.2020.00553 ↗
66. 10.1038/s41577-019-0240-610.1038/s41577-019-0240-6 ↗
67. 10.1002/eji.20174705310.1002/eji.201747053 ↗
68. 10.1038/nm.284710.1038/nm.2847 ↗
69. 10.4103/0974-2727.11984310.4103/0974-2727.119843 ↗
70. 10.1172/JCI6883410.1172/JCI68834 ↗
71. 10.3389/fbioe.2021.66530510.3389/fbioe.2021.665305 ↗